Regencell Bioscience Holdings Limit... (RGC)
$26.7
+1.47 (+5.83%)
Rating:
Recommendation:
-
| Symbol | RGC |
|---|---|
| Price | $26.7 |
| Beta | 0.000 |
| Volume Avg. | 0.00M |
| Market Cap | 347.444M |
| Shares () | - |
| 52 Week Range | 20.54-48.29 |
| 1y Target Est | - |
| DCF Unlevered | RGC DCF -> | |
|---|---|---|
| DCF Levered | RGC LDCF -> | |
| ROE | 1508.28% | Strong Buy |
| ROA | 623.23% | Strong Buy |
| Operating Margin | - | |
| Debt / Equity | 5.50% | Neutral |
| P/E | -47.68 | Strong Sell |
| P/B | 245.66 | Strong Buy |
Latest RGC news
About
Download (Excel)Mr. Yat-Gai Au
Healthcare
Drug Manufacturers—Specialty & Generic
NASDAQ Capital Market
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.